Invention Grant
- Patent Title: Protein ligands
- Patent Title (中): 蛋白质配体
-
Application No.: US11363078Application Date: 2006-02-27
-
Publication No.: US07709209B2Publication Date: 2010-05-04
- Inventor: Sophia Hober , Hans J. Johansson , Tomas Bjorkman
- Applicant: Sophia Hober , Hans J. Johansson , Tomas Bjorkman
- Applicant Address: SE Uppsala
- Assignee: GE Healthcare Bio-Sciences AB
- Current Assignee: GE Healthcare Bio-Sciences AB
- Current Assignee Address: SE Uppsala
- Agent Yonggang Ji
- Priority: SE0200943 20020325
- Main IPC: C07K16/18
- IPC: C07K16/18

Abstract:
The present invention relates to the use of an alkali-stable protein, wherein at least one asparagine residue has been mutated to an amino acid other than glutamine or aspartic acid, which mutation confers an increased chemical stability at pH-values of up to about 13-14 compared to the parental molecule. The protein can for example be derived from a protein capable of binding to other regions of the immunoglobulin molecule than the complementarity determining regions (CDR), such as protein A, and preferably the B-domain of Staphylococcal protein A. The invention also relates to a matrix for affinity separation, which comprises an immunoglobulin-binding protein as ligand coupled to a solid support, in which protein ligand at least one asparagine residue has been mutated to an amino acid other than glutamine.
Public/Granted literature
- US20060194955A1 Protein ligands Public/Granted day:2006-08-31
Information query